Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMDZ7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,368
Award facts
- Contract value 100% obligated
- $15,368.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,368.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of TYMLOS 80 MCG Dose Pen Injectro 1.56ML. This delivery order, issued December 3, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award represents one of numerous delivery orders issued to DMS Pharmaceutical Group through the Defense Logistics Agency's Medical Supply Chain division to support the pharmaceutical requirements of Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency designated as SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. The company's established performance across diverse pharmaceutical categories demonstrates its capability to fulfill specialized requirements within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FMDZ7?
SPE2DR26FMDZ7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FMDZ7 worth?
The government has obligated $15,368 on SPE2DR26FMDZ7.
Is contract SPE2DR26FMDZ7 an order under another contract?
Yes. SPE2DR26FMDZ7 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDZ7 competed?
The extent of competition for SPE2DR26FMDZ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award